Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Friedreich's Ataxia: Case series and the Additive Value of Cardiovascular Magnetic Resonance.

Mavrogeni S, Giannakopoulou A, Katsalouli M, Pons RM, Papavasiliou A, Kolovou G, Noutsias M, Papadopoulos G, Karanasios E, Chrousos GP.

J Neuromuscul Dis. 2019 Nov 27. doi: 10.3233/JND-180373. [Epub ahead of print]

PMID:
31796683
2.

Preparation and characterization of a supramolecular hydrogel made of phospholipids and oleic acid with a high water content.

Talló K, Bosch M, Pons R, Cocera M, López O.

J Mater Chem B. 2019 Nov 29. doi: 10.1039/c9tb01599j. [Epub ahead of print]

PMID:
31782478
3.

Transcirculation Approach for Endovascular Embolization of Intracranial Aneurysms, Arteriovenous Malformations and Dural Fistulas: A Multicenter Study.

Roa JA, Ortega-Gutierrez S, Martinez-Galdamez M, Maud A, Dabus G, Pazour A, Dandapat S, Arteaga MS, Fernandez JG, Paez-Granda D, Kalousek V, Pons RB, Mowla A, Duckwiler G, Szeder V, Jabbour P, Hasan DM, Samaniego EA.

World Neurosurg. 2019 Nov 20. pii: S1878-8750(19)32916-X. doi: 10.1016/j.wneu.2019.11.078. [Epub ahead of print]

PMID:
31759150
4.

Occupational exposure to pesticides and multiple myeloma in the AGRICAN cohort.

Tual S, Busson A, Boulanger M, Renier M, Piel C, Pouchieu C, Pons R, Perrier S, Levêque-Morlais N, Karuranga P, Lemarchand C; AGRICAN-Group, Marcotullio E, Guizard AV, Monnereau A, Baldi I, Lebailly P.

Cancer Causes Control. 2019 Nov;30(11):1243-1250. doi: 10.1007/s10552-019-01230-x. Epub 2019 Sep 18.

PMID:
31535326
5.

Novel PLEC Variant Causes Mild Skin Fragility, Pyloric Atresia, Muscular Dystrophy and Urological Manifestations

Valari M, Theodoraki M, Loukas I, Gkantseva-Patsoura S, Karavana G, Falaina V, Lykopoulou L, Pons R, Athanasiou I, Wertheim-Tysarowska K, Kanaka-Gantenbein C, Kiritsi D.

Acta Derm Venereol. 2019 Sep 12. doi: 10.2340/00015555-3317. [Epub ahead of print] No abstract available.

6.

Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.

Kokkinou E, Roka K, Alexopoulos A, Tsina E, Nikas I, Krallis P, Thanopoulou I, Nasi L, Makrygianni E, Tsoutsou E, Kosma K, Tsipi M, Tzetis M, Frysira H, Kattamis A, Pons R.

Postgrad Med. 2019 Sep;131(7):445-452. doi: 10.1080/00325481.2019.1659708. Epub 2019 Sep 12.

PMID:
31443616
7.

Movement Disorders in Children.

Pearson TS, Pons R.

Continuum (Minneap Minn). 2019 Aug;25(4):1099-1120. doi: 10.1212/CON.0000000000000756.

PMID:
31356295
8.

Antitumor Effects of Anti-Semaphorin 4D Antibody Unravel a Novel Proinvasive Mechanism of Vascular-Targeting Agents.

Zuazo-Gaztelu I, Pàez-Ribes M, Carrasco P, Martín L, Soler A, Martínez-Lozano M, Pons R, Llena J, Palomero L, Graupera M, Casanovas O.

Cancer Res. 2019 Oct 15;79(20):5328-5341. doi: 10.1158/0008-5472.CAN-18-3436. Epub 2019 Jun 25.

PMID:
31239269
9.

Non-surgical therapeutic outcomes of peri-implantitis: 12-month results.

Nart J, Pons R, Valles C, Esmatges A, Sanz-Martín I, Monje A.

Clin Oral Investig. 2019 May 23. doi: 10.1007/s00784-019-02943-8. [Epub ahead of print]

PMID:
31123873
10.

Morphology and severity of peri-implantitis bone defects.

Monje A, Pons R, Insua A, Nart J, Wang HL, Schwarz F.

Clin Implant Dent Relat Res. 2019 Aug;21(4):635-643. doi: 10.1111/cid.12791. Epub 2019 May 14.

PMID:
31087457
11.

Genetic mimics of cerebral palsy.

Pearson TS, Pons R, Ghaoui R, Sue CM.

Mov Disord. 2019 May;34(5):625-636. doi: 10.1002/mds.27655. Epub 2019 Mar 26. Review.

PMID:
30913345
12.

The genetic etiology in cerebral palsy mimics: The results from a Greek tertiary care center.

Zouvelou V, Yubero D, Apostolakopoulou L, Kokkinou E, Bilanakis M, Dalivigka Z, Nikas I, Kollia E, Perez-Dueñas B, Macaya A, Marcé-Grau A, Voutetakis A, Anagnostopoulou K, Kekou K, Sofocleus C, Veltra D, Kokkinis X, Fryssira H, Torres RJ, Amstrong J, Santorelli FM, Artuch R, Pons R.

Eur J Paediatr Neurol. 2019 May;23(3):427-437. doi: 10.1016/j.ejpn.2019.02.001. Epub 2019 Feb 14.

PMID:
30799092
13.

Cationic Niosomes as Non-Viral Vehicles for Nucleic Acids: Challenges and Opportunities in Gene Delivery.

Grijalvo S, Puras G, Zárate J, Sainz-Ramos M, Qtaish NAL, López T, Mashal M, Attia N, Díaz D, Pons R, Fernández E, Pedraz JL, Eritja R.

Pharmaceutics. 2019 Jan 22;11(2). pii: E50. doi: 10.3390/pharmaceutics11020050. Review.

14.

Lung cancer risk and occupational exposures in crop farming: results from the AGRIculture and CANcer (AGRICAN) cohort.

Boulanger M, Tual S, Lemarchand C, Guizard AV, Delafosse P, Marcotullio E, Pons R, Piel C, Pouchieu C, Baldi I, Clin B, Lebailly P; AGRICAN group.

Occup Environ Med. 2018 Nov;75(11):776-785. doi: 10.1136/oemed-2017-104976. Epub 2018 Sep 5.

PMID:
30185443
15.

Cyclobutane Scaffold in Bolaamphiphiles: Effect of Diastereoisomerism and Regiochemistry on Their Surface Activity Aggregate Structure.

Pi-Boleda B, Sorrenti A, Sans M, Illa O, Pons R, Branchadell V, Ortuño RM.

Langmuir. 2018 Sep 25;34(38):11424-11432. doi: 10.1021/acs.langmuir.8b01462. Epub 2018 Sep 13.

PMID:
30173523
16.

Sleep architecture and epileptic characteristics of drug naïve patients in childhood absence epilepsy spectrum. A prospective study.

Dinopoulos A, Tsirouda MA, Bonakis A, Pons R, Pavlopoulou ID, Tsoumakas K.

Seizure. 2018 Jul;59:99-107. doi: 10.1016/j.seizure.2018.04.021. Epub 2018 Apr 30.

17.

Intrafamilial variability in a polish family harbouring a frameshift THAP1 mutation.

Stamelou M, Petrucci S, Ginevrino M, Pons R, Papagiannakis N, Stefanis L, Valente EM.

J Neurol Sci. 2018 May 15;388:158. doi: 10.1016/j.jns.2018.03.026. Epub 2018 Mar 16. No abstract available.

PMID:
29627013
18.

Screening for TSC1 and TSC2 mutations using NGS in Greek children with tuberous sclerosis syndrome.

Papadopoulou A, Dinopoulos A, Koutsodontis G, Pons R, Vorgia P, Koute V, Vratimos A, Zafeiriou D.

Eur J Paediatr Neurol. 2018 May;22(3):419-426. doi: 10.1016/j.ejpn.2018.01.026. Epub 2018 Feb 9.

PMID:
29500070
19.

Nutriosomes: prebiotic delivery systems combining phospholipids, a soluble dextrin and curcumin to counteract intestinal oxidative stress and inflammation.

Catalán-Latorre A, Pleguezuelos-Villa M, Castangia I, Manca ML, Caddeo C, Nácher A, Díez-Sales O, Peris JE, Pons R, Escribano-Ferrer E, Fadda AM, Manconi M.

Nanoscale. 2018 Jan 25;10(4):1957-1969. doi: 10.1039/c7nr05929a.

PMID:
29319093
20.

Stability, biocompatibility and antioxidant activity of PEG-modified liposomes containing resveratrol.

Caddeo C, Pucci L, Gabriele M, Carbone C, Fernàndez-Busquets X, Valenti D, Pons R, Vassallo A, Fadda AM, Manconi M.

Int J Pharm. 2018 Mar 1;538(1-2):40-47. doi: 10.1016/j.ijpharm.2017.12.047. Epub 2017 Dec 30.

PMID:
29294324
21.

Urinary sulphatoxymelatonin as a biomarker of serotonin status in biogenic amine-deficient patients.

Batllori M, Molero-Luis M, Arrabal L, Heras JL, Fernandez-Ramos JA, Gutiérrez-Solana LG, Ibáñez-Micó S, Domingo R, Campistol J, Ormazabal A, Sedel F, Opladen T, Zouvelou B, Pons R, Garcia-Cazorla A, Lopez-Laso E, Artuch R.

Sci Rep. 2017 Nov 7;7(1):14675. doi: 10.1038/s41598-017-15063-8.

22.

Brain and heart magnetic resonance imaging/spectroscopy in duchenne muscular dystrophy.

Mavrogeni S, Pons R, Nikas I, Papadopoulos G, Verganelakis DA, Kolovou G, Chrousos GP.

Eur J Clin Invest. 2017 Dec;47(12). doi: 10.1111/eci.12842. Epub 2017 Oct 26. Review.

PMID:
28981141
23.

Clinical rating scale for pantothenate kinase-associated neurodegeneration: A pilot study.

Darling A, Tello C, Martí MJ, Garrido C, Aguilera-Albesa S, Tomás Vila M, Gastón I, Madruga M, González Gutiérrez L, Ramos Lizana J, Pujol M, Gavilán Iglesias T, Tustin K, Lin JP, Zorzi G, Nardocci N, Martorell L, Lorenzo Sanz G, Gutiérrez F, García PJ, Vela L, Hernández Lahoz C, Ortigoza Escobar JD, Martí Sánchez L, Moreira F, Coelho M, Correia Guedes L, Castro Caldas A, Ferreira J, Pires P, Costa C, Rego P, Magalhães M, Stamelou M, Cuadras Pallejà D, Rodríguez-Blazquez C, Martínez-Martín P, Lupo V, Stefanis L, Pons R, Espinós C, Temudo T, Pérez Dueñas B.

Mov Disord. 2017 Nov;32(11):1620-1630. doi: 10.1002/mds.27129. Epub 2017 Aug 28.

PMID:
28845923
24.

Upper Limb Function, Kinematic Analysis, and Dystonia Assessment in Children With Spastic Diplegic Cerebral Palsy and Periventricular Leukomalacia.

Pons R, Vanezis A, Skouteli H, Papavasiliou A, Tziomaki M, Syrengelas D, Darras N.

J Child Neurol. 2017 Oct;32(11):936-941. doi: 10.1177/0883073817722451. Epub 2017 Aug 4.

PMID:
28776460
25.

Cardiac profile of asymptomatic children with Becker and Duchenne muscular dystrophy under treatment with steroids and with/without perindopril.

Mavrogeni S, Giannakopoulou A, Papavasiliou A, Markousis-Mavrogenis G, Pons R, Karanasios E, Noutsias M, Kolovou G, Papadopoulos G.

BMC Cardiovasc Disord. 2017 Jul 24;17(1):197. doi: 10.1186/s12872-017-0627-x.

26.

Transfection of Antisense Oligonucleotides Mediated by Cationic Vesicles Based on Non-Ionic Surfactant and Polycations Bearing Quaternary Ammonium Moieties.

Mayr J, Grijalvo S, Bachl J, Pons R, Eritja R, Díaz Díaz D.

Int J Mol Sci. 2017 May 26;18(6). pii: E1139. doi: 10.3390/ijms18061139.

27.

ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients.

Carecchio M, Mencacci NE, Iodice A, Pons R, Panteghini C, Zorzi G, Zibordi F, Bonakis A, Dinopoulos A, Jankovic J, Stefanis L, Bhatia KP, Monti V, R'Bibo L, Veneziano L, Garavaglia B, Fusco C, Wood N, Stamelou M, Nardocci N.

Parkinsonism Relat Disord. 2017 Aug;41:37-43. doi: 10.1016/j.parkreldis.2017.05.004. Epub 2017 May 10.

28.

Paroxysmal eye-head movements in Glut1 deficiency syndrome.

Pearson TS, Pons R, Engelstad K, Kane SA, Goldberg ME, De Vivo DC.

Neurology. 2017 Apr 25;88(17):1666-1673. doi: 10.1212/WNL.0000000000003867. Epub 2017 Mar 24.

29.

Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency.

Wassenberg T, Molero-Luis M, Jeltsch K, Hoffmann GF, Assmann B, Blau N, Garcia-Cazorla A, Artuch R, Pons R, Pearson TS, Leuzzi V, Mastrangelo M, Pearl PL, Lee WT, Kurian MA, Heales S, Flint L, Verbeek M, Willemsen M, Opladen T.

Orphanet J Rare Dis. 2017 Jan 18;12(1):12. doi: 10.1186/s13023-016-0522-z. Review.

30.

Congenital Cataracts, Facial Dysmorphism, and Neuropathy Syndrome: Additional Clinical Features.

Makrygianni EA, Papadimas GK, Vartzelis G, Georgala M, Tzetis M, Poulou M, Kitsiou-Tzeli S, Pons R.

Pediatr Neurol. 2017 Feb;67:e5-e6. doi: 10.1016/j.pediatrneurol.2016.11.001. Epub 2016 Nov 21. No abstract available.

PMID:
28041656
31.

Physico-chemical characterization of succinyl chitosan-stabilized liposomes for the oral co-delivery of quercetin and resveratrol.

Caddeo C, Pons R, Carbone C, Fernàndez-Busquets X, Cardia MC, Maccioni AM, Fadda AM, Manconi M.

Carbohydr Polym. 2017 Feb 10;157:1853-1861. doi: 10.1016/j.carbpol.2016.11.072. Epub 2016 Nov 25.

PMID:
27987905
32.

The International Working Group on Neurotransmitter related Disorders (iNTD): A worldwide research project focused on primary and secondary neurotransmitter disorders.

Opladen T, Cortès-Saladelafont E, Mastrangelo M, Horvath G, Pons R, Lopez-Laso E, Fernández-Ramos JA, Honzik T, Pearson T, Friedman J, Scholl-Bürgi S, Wassenberg T, Jung-Klawitter S, Kuseyri O, Jeltsch K, Kurian MA, Garcia-Cazorla À; International Working Group on Neurotransmitter related disorders (iNTD).

Mol Genet Metab Rep. 2016 Oct 20;9:61-66. eCollection 2016 Dec.

33.

Single amino acid loss in the dystrophin protein associated with a mild clinical phenotype.

Pons R, Kekou K, Gkika A, Papadimas G, Vogiatzakis N, Svingou M, Papadopooulos C, Nikas I, Dinopoulos A, Youroukos S, Kanavakis E.

Muscle Nerve. 2017 Jan;55(1):46-50. doi: 10.1002/mus.25190. Epub 2016 Oct 28.

PMID:
27178005
34.

Effect of quercetin and resveratrol co-incorporated in liposomes against inflammatory/oxidative response associated with skin cancer.

Caddeo C, Nacher A, Vassallo A, Armentano MF, Pons R, Fernàndez-Busquets X, Carbone C, Valenti D, Fadda AM, Manconi M.

Int J Pharm. 2016 Nov 20;513(1-2):153-163. doi: 10.1016/j.ijpharm.2016.09.014. Epub 2016 Sep 5.

PMID:
27609664
35.

Analysis of a founder mutation in the TH gene in a cohort of greek patients with Parkinson's disease.

Pons R, Kekou K, Antonellou R, Svingou M, Kanavakis E, Stefanis L.

Mov Disord. 2016 Nov;31(11):1753-1754. doi: 10.1002/mds.26807. Epub 2016 Sep 26. No abstract available.

PMID:
27666733
36.

External genitalia hypertrophy in an adolescent girl with Sanfilippo syndrome.

Bacopoulou F, Apostolaki D, Pons R.

Eur J Contracept Reprod Health Care. 2016 Oct;21(5):412-3. doi: 10.1080/13625187.2016.1217987.

PMID:
27636868
37.

A dynamic trinucleotide repeat (TNR) expansion in the DMD gene.

Kekou K, Sofocleous C, Papadimas G, Petichakis D, Svingou M, Pons RM, Vorgia P, Gika A, Kitsiou-Tzeli S, Kanavakis E.

Mol Cell Probes. 2016 Aug;30(4):254-260. doi: 10.1016/j.mcp.2016.07.001. Epub 2016 Jul 12.

PMID:
27417533
38.

Chiral Cyclobutane β-Amino Acid-Based Amphiphiles: Influence of Cis/Trans Stereochemistry on Condensed Phase and Monolayer Structure.

Sorrenti A, Illa O, Ortuño RM, Pons R.

Langmuir. 2016 Jul 12;32(27):6977-84. doi: 10.1021/acs.langmuir.6b01461. Epub 2016 Jun 30.

PMID:
27327214
39.

A series of Greek children with pure hereditary spastic paraplegia: clinical features and genetic findings.

Polymeris AA, Tessa A, Anagnostopoulou K, Rubegni A, Galatolo D, Dinopoulos A, Gika AD, Youroukos S, Skouteli E, Santorelli FM, Pons R.

J Neurol. 2016 Aug;263(8):1604-11. doi: 10.1007/s00415-016-8179-z. Epub 2016 Jun 3.

PMID:
27260292
40.

Santosomes as natural and efficient carriers for the improvement of phycocyanin reepithelising ability in vitro and in vivo.

Castangia I, Manca ML, Caddeo C, Bacchetta G, Pons R, Demurtas D, Diez-Sales O, Fadda AM, Manconi M.

Eur J Pharm Biopharm. 2016 Jun;103:149-158. doi: 10.1016/j.ejpb.2016.03.033. Epub 2016 Apr 1.

PMID:
27045470
41.

New cationic vesicles prepared with double chain surfactants from arginine: Role of the hydrophobic group on the antimicrobial activity and cytotoxicity.

Pinazo A, Petrizelli V, Bustelo M, Pons R, Vinardell MP, Mitjans M, Manresa A, Perez L.

Colloids Surf B Biointerfaces. 2016 May 1;141:19-27. doi: 10.1016/j.colsurfb.2016.01.020. Epub 2016 Jan 14.

42.

Factors associated with medication adherence in patients living with cirrhosis.

Polis S, Zang L, Mainali B, Pons R, Pavendranathan G, Zekry A, Fernandez R.

J Clin Nurs. 2016 Jan;25(1-2):204-12. doi: 10.1111/jocn.13083. Erratum in: J Clin Nurs. 2017 Nov;26(21-22):3751.

PMID:
26769208
43.

Alberta Infant Motor Scale (AIMS) Performance of Greek Preterm Infants: Comparisons With Full-Term Infants of the Same Nationality and Impact of Prematurity-Related Morbidity Factors.

Syrengelas D, Kalampoki V, Kleisiouni P, Manta V, Mellos S, Pons R, Chrousos GP, Siahanidou T.

Phys Ther. 2016 Jul;96(7):1102-8. doi: 10.2522/ptj.20140494. Epub 2015 Dec 4.

PMID:
26637651
44.

Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.

Garcia-Aguilar J, Renfro LA, Chow OS, Shi Q, Carrero XW, Lynn PB, Thomas CR Jr, Chan E, Cataldo PA, Marcet JE, Medich DS, Johnson CS, Oommen SC, Wolff BG, Pigazzi A, McNevin SM, Pons RK, Bleday R.

Lancet Oncol. 2015 Nov;16(15):1537-1546. doi: 10.1016/S1470-2045(15)00215-6. Epub 2015 Oct 22.

45.

Cross-linked chitosan/liposome hybrid system for the intestinal delivery of quercetin.

Caddeo C, Díez-Sales O, Pons R, Carbone C, Ennas G, Puglisi G, Fadda AM, Manconi M.

J Colloid Interface Sci. 2016 Jan 1;461:69-78. doi: 10.1016/j.jcis.2015.09.013. Epub 2015 Sep 5.

PMID:
26397912
46.

Chiral Cyclobutane β-Amino Acid-Based Amphiphiles: Influence of Cis/Trans Stereochemistry on Solution Self-Aggregation and Recognition.

Sorrenti A, Illa O, Pons R, Ortuño RM.

Langmuir. 2015 Sep 8;31(35):9608-18. doi: 10.1021/acs.langmuir.5b02700. Epub 2015 Aug 21.

PMID:
26286019
47.

Faceted phospholipid vesicles tailored for the delivery of Santolina insularis essential oil to the skin.

Castangia I, Manca ML, Caddeo C, Maxia A, Murgia S, Pons R, Demurtas D, Pando D, Falconieri D, Peris JE, Fadda AM, Manconi M.

Colloids Surf B Biointerfaces. 2015 Aug 1;132:185-93. doi: 10.1016/j.colsurfb.2015.05.025. Epub 2015 May 22.

PMID:
26057243
48.

Effect of fatty acids on self-assembly of soybean lecithin systems.

Godoy CA, Valiente M, Pons R, Montalvo G.

Colloids Surf B Biointerfaces. 2015 Jul 1;131:21-8. doi: 10.1016/j.colsurfb.2015.03.065. Epub 2015 Apr 21.

PMID:
25938851
49.

Cerebrospinal fluid synaptic proteins as useful biomarkers in tyrosine hydroxylase deficiency.

Ortez C, Duarte ST, Ormazábal A, Serrano M, Pérez A, Pons R, Pineda M, Yapici Z, Fernández-Álvarez E, Domingo-Jiménez R, De Castro P, Artuch R, García-Cazorla A.

Mol Genet Metab. 2015 Jan;114(1):34-40. doi: 10.1016/j.ymgme.2014.10.014. Epub 2014 Oct 31.

PMID:
25468651
50.

Niosomes based on synthetic cationic lipids for gene delivery: the influence of polar head-groups on the transfection efficiency in HEK-293, ARPE-19 and MSC-D1 cells.

Ojeda E, Puras G, Agirre M, Zárate J, Grijalvo S, Pons R, Eritja R, Martinez-Navarrete G, Soto-Sanchez C, Fernández E, Pedraz JL.

Org Biomol Chem. 2015 Jan 28;13(4):1068-81. doi: 10.1039/c4ob02087a. Epub 2014 Nov 21.

PMID:
25412820

Supplemental Content

Support Center